サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1217165

遺伝子編集の世界市場レポート 2023年

Gene Editing Global Market Report 2023
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.88円
遺伝子編集の世界市場レポート 2023年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

世界の遺伝子編集市場は、2022年の63億5000万米ドルから2023年には74億4000万米ドルへ、年平均成長率（CAGR）17.3％で拡大する見込みです。ロシア・ウクライナ戦争は、少なくとも短期的には、COVID-19パンデミックからの世界経済回復の可能性を混乱させました。この2国間の戦争は、複数の国に対する経済制裁、商品価格の高騰、サプライチェーンの混乱につながり、商品やサービス全体にインフレを引き起こし、世界中の多くの市場に影響を及ぼしています。遺伝子編集市場は、2027年にはCAGR17.7%で142億8000万米ドルに成長すると予想されています。

2022年の遺伝子編集市場では、北米が最大の地域となっています。西欧は、遺伝子編集市場で2番目に大きな地域でした。遺伝子編集市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 遺伝子編集市場の特徴

第3章 遺伝子編集市場の動向と戦略

第4章 遺伝子編集市場- マクロ経済シナリオ

第5章 遺伝子編集の市場規模と成長

  • 世界の遺伝子編集市場の実績、2017年から2022年
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の遺伝子編集市場の予測、2022-2027F、2032F
    • 市場の促進要因
    • 市場の抑制要因

第6章 遺伝子編集市場セグメンテーション

  • 世界の遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • CRISPR
  • TALEN
  • ZFN
  • 世界の遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • バイオテクノロジー
  • 医薬品
  • 受託調査機関
  • 世界の遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 動物遺伝子エンジニアリング
  • 植物遺伝子エンジニアリング
  • 細胞株エンジニアリング

第7章 遺伝子編集市場の地域および国の分析

  • 世界の遺伝子編集市場、地域別、実績と予測、2017-2022、2022-2027F、2032F
  • 世界の遺伝子編集市場、国別、実績と予測、2017-2022、2022-2027F、2032F

第8章 アジア太平洋の遺伝子編集市場

  • アジア太平洋の遺伝子編集市場概要
  • 地域情報, COVID-19の影響,市場情報,背景情報,政府のイニシアチブ,規制,規制機関,主要団体,課税される税,法人税構造,投資,主要企業
  • アジア太平洋の遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • アジア太平洋の遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • アジア太平洋の遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第9章 中国の遺伝子編集市場

  • 中国の遺伝子編集市場概要
  • 中国の遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 中国の遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 中国の遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第10章 インドの遺伝子編集市場

  • インドの遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インドの遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インドの遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第11章 日本の遺伝子編集市場

  • 日本の遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 日本の遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 日本の遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第12章 オーストラリアの遺伝子編集市場

  • オーストラリアの遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • オーストラリアの遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • オーストラリアの遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第13章 インドネシアの遺伝子編集市場

  • インドネシアの遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インドネシアの遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • インドネシアの遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第14章 韓国の遺伝子編集市場

  • 韓国の遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 韓国の遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 韓国の遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第15章 西欧の遺伝子編集市場

  • 西欧の遺伝子編集市場概要
  • 西欧の遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 西欧の遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 西欧の遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第16章 英国の遺伝子編集市場

  • 英国の遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 英国の遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 英国の遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第17章 ドイツの遺伝子編集市場

  • ドイツの遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ドイツの遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ドイツの遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第18章 フランスの遺伝子編集市場

  • フランス遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • フランスの遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • フランスの遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第19章 東欧の遺伝子編集市場

  • 東欧の遺伝子編集市場概要
  • 東欧の遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 東欧の遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 東欧の遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第20章 ロシアの遺伝子編集市場

  • ロシアの遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ロシアの遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ロシアの遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第21章 北米の遺伝子編集市場

  • 北米の遺伝子編集市場概要
  • 北米遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 北米遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 北米の遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第22章 米国の遺伝子編集市場

  • 米国の遺伝子編集市場概要
  • 米国の遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 米国の遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 米国の遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第23章 南米の遺伝子編集市場

  • 南米の遺伝子編集市場概要
  • 南米の遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 南米の遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 南米の遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第24章 ブラジルの遺伝子編集市場

  • ブラジルの遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ブラジルの遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • ブラジルの遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第25章 中東の遺伝子編集市場

  • 中東の遺伝子編集市場概要
  • 中東遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 中東の遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • 中東遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第26章 アフリカの遺伝子編集市場

  • アフリカの遺伝子編集市場概要
  • アフリカ遺伝子編集市場、技術別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • アフリカの遺伝子編集市場、エンドユーザー別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F
  • アフリカの遺伝子編集市場、アプリケーション別セグメンテーション、実績と予測、2017-2022、2022-2027F、2032F

第27章 遺伝子編集市場の競合情勢と企業プロファイル

  • 遺伝子編集市場の競合情勢
  • 遺伝子編集市場の企業プロファイル
    • CRISPR
    • GenScript USA Inc
    • Horizon Discovery Group plc
    • Integrated DNA Technologies
    • New England Biolabs

第28章 遺伝子編集市場における主要な合併と買収

第29章 遺伝子編集市場の将来展望と可能性分析

第30章 付録

目次
Product Code: r2273

“Gene Editing Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene editing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene editing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The gene editing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Technology: CRISPR; TALEN; ZFN

2) By End Users: Biotechnology; Pharmaceutical; Contract Research Organization

3) By Application: Animal Genetic Engineering; Plant Genetic Engineering; Cell Line Engineering

Companies Mentioned: CRISPR; GenScript USA Inc.; Horizon Discovery Group plc; Integrated DNA Technologies; New England Biolabs

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the gene editing market are: CRISPR, GenScript USA Inc, Horizon Discovery Group plc, Integrated DNA Technologies, New England Biolabs, OriGene Technologies, Thermo Fisher Scientific, Merck KgaA, GenScript Corporation, Editas Medicine, Lonza Group, Sangamo, DNA 2.0, Bio RAD, Allele, Addgene, Sigma-Aldrich Corporation, Transposagen Biopharmaceuticals, Recombinetics, Precision Biosciences, Promega, Juno Therapeutics, Intellia Therapeutics, Qiagen, GE Healthcare Lonza, Cellectis, Dharmacon, AstraZeneca, and Agilent Technologies.

The global gene editing market will grow from $6.35 billion in 2022 to $7.44 billion in 2023 at a compound annual growth rate (CAGR) of 17.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The gene editing market is expected to grow to $14.28 billion in 2027 at a CAGR of 17.7%.

The gene editing market includes revenue earned by zinc-finger nucleases (ZFNs) and homing endonucleases or meganucleases. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Gene editing is a technology that allows genetic material to change genetic code at particular location in a genome. It involves cell line engineering, animal genetic engineering and plant genetic engineering.

North America was the largest region in the gene editing market in 2022. Western Europe was the second largest region in the gene editing market. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main technology types of gene editing are CRISPR, TALEN, and ZFN. CRISPR is a novel technology that allows geneticists and medical researchers to edit parts of the genome by removing, inserting, or modifying DNA sequences. The various application includes biotechnology, pharmaceutical, and contract research organization that are used by animal genetic engineering, plant genetic engineering, and cell line engineering.

The rising infectious diseases act as one of the major drivers of the gene editing market. Gene editing techniques are used for the detection of infectious diseases such as HIV. Infectious diseases are caused by microorganisms like bacteria, viruses, fungi, and parasites. Gene therapy treats infectious diseases by blocking the replication of the infectious agent that causes the disease at the extracellular level. Gene editing introduces new genetic material into the cells of living organisms with the intention of treating diseases.

Infectious diseases are constantly on the rise. For instance, according to the World Health Organization (WHO), infectious diseases kill more than 17 million people per year. In addition to that, according to the AP-NORC (a research initiative by the Associated Press and the University of Chicago) survey, out of 1,067 adults in the US surveyed, 71% are in favor of gene editing for the treatment of incurable, hereditary diseases such as Huntington's disease and 67% of Americans support the use of gene editing to prevent diseases such as cancer.

Ethical issues in general public with respect to gene editing is one of the major restraining factors for the market. Many researchers and ethicist have argued against gene editing due to different reasons such as off-target effect (edits in the wrong place), mosaicism (when only some of the cells carry the edits) and safety concerns. Some even argued that gene editing will lead to the creation of classes of individuals who will be genetically modified to be able to do things that a normal human being is not supposed to do according to the laws of nature. Due to these reasons, gene editing is still not considered to be safe and effective by many nations and international organizations. For instance, in 2020, as per the article published in TIME, scientists from Canada, China, France, Germany, Italy, New Zealand, and the USA have proposed a temporary prohibition on research on gene editing on human eggs, embryos, and sperms.

Gene editing (also called genome editing) is a group of technologies that allow the researchers to change an organism's DNA by adding, removing or altering genetic material at particular locations in the genome. The emergence of advanced genome editing techniques is one of the major trends in the gene editing market. The new techniques in genome editing are relatively inexpensive and can be used in a variety of application areas such as improving the food supply in agriculture, rectifying specific genetic mutations in the human genome and preventing the spread of diseases. For instance, CRISPR-Cas9 is a gene editing technique and stands for Clustered Regularly Interspace Short Palindromic Repeats. The technique uses a strand of DNA as molecular scissors used to make cuts in DNA at specific points to make space to add new genomes. This technique is faster, cheaper, more accurate and efficient than other existing genome editing methods. Companies investing in CRISPR technology are Crispr therapeutics (CRSP), Intellia Therapeutics (NTLA), and Editas medicine.

European regulatory framework divided gene therapy into two categories, germline gene therapy, and somatic gene therapy. In germ line gene therapy, modified genes will be passed on to next generations whereas it's not the same case with somatic gene therapy. Current regulation by the EU has only allowed somatic gene therapy, therefore, germline gene therapy is banned. The European Medical Association provides guidelines on gene therapy for preparing market authorization application to obtain approval from the authority to carry on research and development activities in gene therapy. For instance, the EU provides guidance note on gene therapy medicinal product which is intended for use in humans, defines scientific principles and provide guidance for development and evaluation of gene therapy products.

In December 2020, AnGes MG, Inc., a Japan based biopharmaceutical company that offers nucleic acid drugs for patients with asthma, allergy, and rheumatism acquired Emendo Bio, Inc for $250M. This acquisition will expand AnGes MG, Inc. pipeline and partnerships and introduce gene editing capabilities. Emendo Bio, Inc, a USA based company that develops next generation gene editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy.

The countries covered in the market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

The gene editing market research report is one of a series of new reports from The Business Research Company that provides gene editing market statistics, including gene editing industry global market size, regional shares, competitors with a gene editing market share, detailed gene editing market segments, market trends and opportunities, and any further data you may need to thrive in the gene editing industry. This gene editing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Gene Editing Market Characteristics

3. Gene Editing Market Trends And Strategies

4. Gene Editing Market - Macro Economic Scenario

4.1 COVID-19 Impact On Gene Editing Market

4.2 Ukraine-Russia War Impact On Gene Editing Market

4.3 Impact Of High Inflation On Gene Editing Market

5. Gene Editing Market Size And Growth

  • 5.1. Global Gene Editing Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Gene Editing Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Gene Editing Market Segmentation

  • 6.1. Global Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • CRISPR
  • TALEN
  • ZFN
  • 6.2. Global Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Biotechnology
  • Pharmaceutical
  • Contract Research Organization
  • 6.3. Global Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Animal Genetic Engineering
  • Plant Genetic Engineering
  • Cell Line Engineering

7. Gene Editing Market Regional And Country Analysis

  • 7.1. Global Gene Editing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Gene Editing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Gene Editing Market

  • 8.1. Asia-Pacific Gene Editing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.4. Asia-Pacific Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Gene Editing Market

  • 9.1. China Gene Editing Market Overview
  • 9.2. China Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.4. China Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Gene Editing Market

  • 10.1. India Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.3. India Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Gene Editing Market

  • 11.1. Japan Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.3. Japan Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Gene Editing Market

  • 12.1. Australia Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.3. Australia Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Gene Editing Market

  • 13.1. Indonesia Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.3. Indonesia Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Gene Editing Market

  • 14.1. South Korea Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.3. South Korea Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Gene Editing Market

  • 15.1. Western Europe Gene Editing Market Overview
  • 15.2. Western Europe Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.4. Western Europe Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Gene Editing Market

  • 16.1. UK Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.3. UK Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Gene Editing Market

  • 17.1. Germany Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.3. Germany Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Gene Editing Market

  • 18.1. France Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.3. France Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Gene Editing Market

  • 19.1. Eastern Europe Gene Editing Market Overview
  • 19.2. Eastern Europe Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.4. Eastern Europe Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Gene Editing Market

  • 20.1. Russia Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.3. Russia Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Gene Editing Market

  • 21.1. North America Gene Editing Market Overview
  • 21.2. North America Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.4. North America Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Gene Editing Market

  • 22.1. USA Gene Editing Market Overview
  • 22.2. USA Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.4. USA Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Gene Editing Market

  • 23.1. South America Gene Editing Market Overview
  • 23.2. South America Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.4. South America Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Gene Editing Market

  • 24.1. Brazil Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.3. Brazil Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Gene Editing Market

  • 25.1. Middle East Gene Editing Market Overview
  • 25.2. Middle East Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.4. Middle East Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Gene Editing Market

  • 26.1. Africa Gene Editing Market Overview
  • 26.2. Africa Gene Editing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Gene Editing Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.4. Africa Gene Editing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Gene Editing Market Competitive Landscape And Company Profiles

  • 27.1. Gene Editing Market Competitive Landscape
  • 27.2. Gene Editing Market Company Profiles
    • 27.2.1. CRISPR
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. GenScript USA Inc
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Horizon Discovery Group plc
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Integrated DNA Technologies
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. New England Biolabs
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Gene Editing Market

29. Gene Editing Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer